Category: Medical device company
Industry: Drug Manufacturers - Major Quick infos Headquarters: New Brunswick, New Jersey, United States Trade prices Volume: 6.1M Market Cap: 421.49B Prev closed: 150.97 Open: 151.6 High: 153.14 Low: 151.02 52 week low: 109.16 52 week high: 157 Dividends: Next ER: October 19, 2021 Before Market Opens
About the Company Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company founded in 1886.
Earnings History Date EPS / Forecast Revenue / Forecast January 25, 2022 October 19, 2021 2.6 / 2.3623.34B / 23.66BJuly 21, 2021 2.48 / 2.2923.31B / 22.49BBeat! April 20, 2021 2.59 / 2.3422.32B / 21.98BBeat! January 26, 2021 1.86 / 1.8222.48B / 21.66BBeat! view more
Historical Data Date Price Open High Low Vol Change ER Nov 29, 2021 159.75 159.50 160.42
158.42
9.18M 0.35% Nov 26, 2021 159.20 160.60 161.16
158.66
7.08M -0.65% Nov 24, 2021 160.24 160.14 160.62
159.38
5.23M -0.28% Nov 23, 2021 160.69 159.52 161.00
158.78
7.72M 0.62% Nov 22, 2021 159.70 161.03 162.64
159.65
7.60M -1.96% Nov 19, 2021 162.89 163.04 163.19
161.78
7.63M 0.30% Nov 18, 2021 162.40 163.45 164.47
162.13
6.36M -0.54% Nov 17, 2021 163.28 162.87 163.86
161.79
5.38M 0.37% Nov 16, 2021 162.67 163.18 164.35
162.62
7.39M -0.52% Nov 15, 2021 163.52 165.00 165.46
163.22
7.50M -0.9% view more
NYSE - New York Stock Exchange
More profiles and info about the company ISIN: US4781601046 CUSIP: 478160104 Founded:January 1886 Employees:126,400 News
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2020 johnsonandjohnson.gcs-web.com Jul 21, 2020 1:40 am Johnson & Johnson to Participate in Citi ‘Of Hearts and Minds’ Conference Call Series johnsonandjohnson.gcs-web.com Jul 17, 2020 11:30 pm Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement in Patients Living with X-Linked Retinitis Pigmentosa johnsonandjohnson.gcs-web.com Jul 17, 2020 9:00 pm Pfizer CEO: COVID is here to stay, but we should be able to control it seekingalpha.com Oct 20, 2021 12:45 am J&J CFO: Revenue miss was a matter of timing in vaccine, medical device businesses seekingalpha.com Oct 19, 2021 9:34 pm Hot Stocks: PG, JNJ dip on earnings; WMT analyst comment; TASK stock offering; HRMY added to index seekingalpha.com Oct 19, 2021 8:47 pm Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 years and Older johnsonandjohnson.gcs-web.com Nov 24, 2021 10:00 pm European Commission Approves BYANNLI® (6-monthly Paliperidone Palmitate; PP6M) for the Maintenance Treatment of Schizophrenia in Adults johnsonandjohnson.gcs-web.com Nov 23, 2021 10:00 pm Late-Breaking Phase 2 Data for Investigational Oral Factor XIa Inhibitor Milvexian Suggest Favorable Antithrombotic Profile Across a Wide Range of Doses johnsonandjohnson.gcs-web.com Nov 15, 2021 10:00 pm Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business johnsonandjohnson.gcs-web.com Nov 12, 2021 7:37 pm Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World’s Most Vulnerable People through Novel Humanitarian Buffer johnsonandjohnson.gcs-web.com Nov 10, 2021 10:00 pm Janssen to Present the Strength and Promise of its Hematologic Malignancies Portfolio and Pipeline at ASH 2021 johnsonandjohnson.gcs-web.com Nov 4, 2021 11:00 pm Janssen Announces Extension of U.S. FDA BLA PDUFA Date for BCMA CAR-T Ciltacabtagene Autoleucel johnsonandjohnson.gcs-web.com Nov 1, 2021 10:00 pm New Comprehensive Phase 3 Data Show First-in-Class TREMFYA® (guselkumab) Provided Durable Improvements in Measures of Psoriatic Arthritis (PsA) Disease Activity Through Two Years johnsonandjohnson.gcs-web.com Nov 1, 2021 9:30 pm New Phase 3 First-in-Class TREMFYA® (guselkumab) Data Show Durability of Joint Efficacy, Including Low Rates of Structural Damage Progression, and a Demonstrated Safety Profile in Adults with Active Psoriatic Arthritis (PsA) johnsonandjohnson.gcs-web.com Nov 1, 2021 9:00 pm New Analyses Suggest Favorable Results for STELARA® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis johnsonandjohnson.gcs-web.com Oct 25, 2021 9:30 pm U.S. CDC Advisory Committee Unanimously Recommends Johnson & Johnson COVID-19 Vaccine as a Booster for All Eligible Individuals Who Receive Authorized COVID-19 Vaccines johnsonandjohnson.gcs-web.com Oct 22, 2021 4:00 am Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2021 johnsonandjohnson.gcs-web.com Oct 22, 2021 2:45 am Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA johnsonandjohnson.gcs-web.com Oct 21, 2021 6:38 am Johnson & Johnson Reports Q3 2021 Results johnsonandjohnson.gcs-web.com Oct 19, 2021 9:30 pm JNJ Dividends Ex-Dividend Amount Announced Date Record Date Payment Date Nov 22, 2021 1.06 Dec 7, 2021 Aug 23, 2021 1.06 Sep 7, 2021 May 24, 2021 1.06 Jun 8, 2021 Feb 22, 2021 1.01 Mar 9, 2021 Nov 23, 2020 1.01 Dec 8, 2020 view more
Key Persons Talk about Johnson below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Homepage: jnj.com Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.
A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology
